Tag: biotech

Health & Healthcare

The case for constant innovation in Australian biotech

Melbourne – 12th October 2010 – The sales contribution from internally developed products is expected to decline from $284 billion in 2009 to $274 billion in 2014, by which time the majority of sales will be derived from externally sourced products. Pharma’s continued need to restock pipelines in order to secure future growth—in the face…

12 Oct 2010, by Informa Australia